Evidence map›Paper›PMID 40871522›Full record

ReviewMolecules (Basel, Switzerland)2025

Silane-Coupled Silica Nanoparticles Encapsulating Emitting Quantum Dots: Advancing Robust Phosphors for Displays and Beyond.

Norio Murase, Chunliang Li

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Norio MuraseKansai Collaboration Center, National Institute of Advanced Industrial Science and Technology (AIST), Ikeda 563-8577, Osaka, Japan.ORCID 0000-0001-9687-0104
Chunliang LiSchool of Materials Science and Engineering, Tianjin University of Technology, Xiqing, Tianjin 300384, China.ORCID 0000-0003-3826-8400

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colloidal quantum dots (QDs) are semiconductor crystals a few nanometers in size. Due to their vibrant colors and unique photoluminescence (PL), QDs are widely utilized in displays, where barrier films provide essential shielding. However, one of the primary challenges of QD applications remains achieving sufficient robustness while keeping costs low. Over the past two decades, significant progress has been made in the encapsulation of QDs within silica matrices, aiming to preserve their original PL properties. Research efforts have evolved from bulk forms to thin films. Silica nanoparticles containing multiple embedded QDs have emerged as particularly promising candidates for practical applications. This review highlights recent advancements in silica-based QD encapsulation, incorporating findings from both the authors' investigations and those of other research groups within the field. Silica glass possesses inherent shielding capabilities, but silane coupling agents such as (3-aminopropyl)trimethoxysilane and (3-mercaptopropyl)trimethoxysilane tend to negatively impact this functionality when they are used alone, partly because of the limited formation of a well-developed glass network structure. However, when judiciously controlled, they can serve as mediators between the QD surface and the surrounding pure silica glass matrix, helping to preserve PL properties and control the morphology of silica particles. This review discusses the potential for achieving exceptional shielding properties through sol-gel glass fabrication at low temperatures, utilizing both tetraethoxysilane and other silane coupling agents.

Indexed as

colloidal quantum dotphotoluminescenceprotectionsilane-coupling agentsol-gel

Identifiers

PMID40871522
PMCPMC12388236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.